Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients

NCT00789854 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

688

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder
Treatment Resistant Depression

Interventions

DRUG: Quetiapine XR
DRUG: Lithium carbonate
DRUG: SSRI/Venlafaxine

Sponsor

AstraZeneca